A rank-based randomized phase II design when the phase III design is based on overall survival (OS)
Mietlowski, William Leonard, Ma, Fei, Bao, Weichao, Chung, Yunro, Shi, Michael, Wood, Patricia Ann, Porro, Maria Grazia
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Patient-reported quality of life (QOL) following CTL019 in pediatric and young adult patients (pts) with relapsed/refractory (r/r) b-cell acute lymphoblastic leukemia (B-ALL)
Dietz, Andrew Charles, Grupp, Stephan A., Laetsch, Theodore Willis, Stefanski, Heather, Myers, Gary Douglas, Bittencourt, Henrique, Buechner, Jochen, Nemecek, Eneida R., Martin, Paul L., Hiramatsu, Hidefumi, Mechinaud, Francoise, Yanik, Gregory A., De Moerloose, Barbara, Wood, Patricia Ann, Rasouliyan, Lawrence, Zhang, Yiyun, Thomas, Simu K., Shah, Sweta, Harris, Andrew
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Effect of evening melatonin on the survival of patients with advanced non-small cell lung cancer (ANSCLC)
Lis, Christopher G., Levin, Robert D., Grutsch, James F., Birdsall, Timothy C., Wood, Patricia Ann, Huff, Dinah Faith Q, Reynolds, Justin, Daehler, Mary Ann, Pearl, Dennis, Shen, Xiaoping, Blask, David E, Hrushesky, William J.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Clinical importance of including new and nontarget lesion assessment of disease progression (PD) to predict overall survival (OS): Implications for randomized phase II study design
Mietlowski, William Leonard, Bao, Weichao, Wood, Patricia Ann, Williams, Denise E, El-Hashimy, Mona, Sarr, Celine, Stein, Andrew Marc, Shi, Michael, Weber, Dirk, Habr, Dany, Porro, Maria Grazia
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
A phase II, dose-optimization trial of autologous T cells genetically engineered to express anti-CD19 chimeric antigen receptor (CART-19) in patients with relapsed or refractory (r/r) CD19+ chronic lymphocytic leukemia (CLL)
Porter, David L., Frey, Noelle V., Loren, Alison W., Levine, Bruce, Kalos, Michael, McConville, Holly, Gilmore, Joan, Chew, Anne, Shen, Angela, So, Charlene, Sharr, Michele, Wood, Patricia Ann, June, Carl H.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Biosynthetic determination of turn-over rates of various plasma proteins in normal and cirrhotic man
Volwiler, Wade, Goldsworthy, Patrick D., MacMartin, Marion P., Wood, Patricia Ann, Douglas, Gertrude, Mackay, Iran R.
Published in The American journal of medicine (01.07.1954)
Published in The American journal of medicine (01.07.1954)
Get full text
Journal Article
BIOSYNTHETIC DETERMINATION WITH RADIOACTIVE SULFUR OF TURN-OVER RATES OF VARIOUS PLASMA PROTEINS IN NORMAL AND CIRRHOTIC MAN 12
Volwiler, Wade, Goldsworthy, Patrick D., MacMartin, Marion P., Wood, Patricia Ann, Mackay, Ian R., Fremont-Smith, Kenneth
Published in The Journal of clinical investigation (01.07.1955)
Published in The Journal of clinical investigation (01.07.1955)
Get full text
Journal Article
Quantitation of gamma globulins in human serum by immunoprecipitation
BARRETT, B, WOOD, P A, VOLWILER, W
Published in The Journal of laboratory and clinical medicine (01.04.1960)
Get more information
Published in The Journal of laboratory and clinical medicine (01.04.1960)
Journal Article